EP300 and esophageal cancer: Emerging studies have discovered that STAT3, p300 and MMP19 are overexpressed in breast cancer [36], esophageal cancer [37], colorectal cancer (CRC) [38] or NSCLC [15] and so on [16,31], promoting cancer cell growth or metastasis.